Open App →
Back to News Feed
PR Newswire September 30, 2026 positive

Medtronic announces regulatory milestones for newest cardiac mapping and ablation software

<p>FDA clearance and CE Mark for latest Affera™ Prism-2 Mapping Software expand cardiac mapping capabilities CE Mark for PulseSelect ProxBox™ Adapter with Proximity Indicator software adds real-time tissue proximity feedback GALWAY, Ireland, Sept. 30, 2026 /PRNewswire/ -- Medtronic (NYSE:...</p>
Read original article ↗